CN Patent

CN101087781A — 用于治疗肺结核的吲哚衍生物

Assigned to AstraZeneca AB · Expires 2007-12-12 · 18y expired

What this patent protects

式(I)化合物或其可药用盐或其在体内可水解的酯在制备用于治疗结核分枝杆菌(M.tb)的药物中的应用。

USPTO Abstract

式(I)化合物或其可药用盐或其在体内可水解的酯在制备用于治疗结核分枝杆菌(M.tb)的药物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number: CN101087781A
Jurisdiction: CN
Classification: —
Expires: 2007-12-12
Drug substance claim: No
Drug product claim: No
Assignee: AstraZeneca AB
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.